3.
12例COVID-19心脏损伤评估指标
Cardiac injury assessment indexes of the COVID-19 patients
| Cardiac injury assessment indexes | Normal range | Case 1 | Case2 | Case 3 | Case 4 | Case 5 | Case 6 | Case 7 | Case 8 | Case 9 | Case 10 | Case 11 | Case 12 | Abnormal rate (%) |
| Heart rate (beats/min) |
60-100 | 86 | 102 | 65 | 92 | 112 | 118 | 106 | 84 | 74 | 68 | 84 | 78 | 25.0 |
| Creatine kinase MB (CKMB, U/L) |
0-24 | 15 | 14 | 16 | 10 | 11 | 74 | 8 | 19 | 12 | 8 | 12 | 7 | 8.3 |
| Troponin I (aTnI, ng/Ml) |
0-0.04 | 0.001 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| B-type natriuretic peptide (BNP, pg/mL) |
0-300 | 220 | 60 | 120 | 30 | 205.3 | 556.2 | 280 | 20 | 125 | 224 | 60.7 | < 18 | 8.3 |
| New ECG changes (new arrhythmia or block or ST-T changes) |
- | Premature beat | No | No | No | Premature beat | Premature beat depressed ST | No | No | No | No | No | Premature beat | 33.3 |
| Left ventricular ejection fraction (LVEF, %) |
≥55 | 65 | 71 | 75 | 74 | 63 | 65 | 68 | 75 | 67 | 72 | 70 | 71 | 0 |
| Global longitudinal strain(GLS) | ≤-20 | -17.8 | -22 | -22 | -26 | -16.5 | -14.2 | -18.2 | 28 | -25 | -27 | -26 | -28 | 25 |